Q BioMed Inc.
company.status.inactiveCIK 1596062fmd_18TBKHQWF8QD4Z3WYHTTWJ7FKYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Dec 01, 2012 to Feb 28, 2023, 38 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Net investment income | – | – | (1) | (7) | (15) | (9) | – | – | – | – |
| Cost of revenue | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Gross profit | – | – | – | – | – | – | – | (0) | (0) | (0) |
| Research and development | – | – | 1 | 1 | 3 | 3 | 4 | 2 | 1 | 0 |
| Selling, general and administrative | – | – | 0 | – | – | – | – | – | – | – |
| Total operating expenses | 0 | 0 | 1 | 6 | 12 | 9 | 8 | 13 | 7 | 3 |
| Operating income | (0) | (0) | – | – | – | – | – | (13) | (7) | (3) |
| Interest expense | – | – | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 1 |
| Other non-operating income (expense) | – | – | – | – | – | – | – | – | (1) | 1 |
| Income before taxes | – | – | – | – | – | – | (8) | (13) | (7) | – |
| Net income | (0) | (0) | (1) | (7) | (15) | (9) | (10) | (13) | (8) | (2) |
| Net income to common shareholders | – | – | 1 | 7 | 7 | 15 | (10) | (14) | (9) | (3) |